N-[(5-chloro-8-hydroxyquinolin-7-yl)thiophen-2-ylmethyl]-2-methylpropanamide

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 英文名称: N-[(5-chloro-8-hydroxyquinolin-7-yl)thiophen-2-ylmethyl]-2-methylpropanamide
• 英文别名: N-[(5-chloro-8-hydroxyquinolin-7-yl)(2-thienyl)methyl]-2-methylpropanamide；N-[(5-chloro-8-hydroxy-7-quinolyl)-(2-thienyl)methyl]-2-methyl-propanamide；N-[(5-chloro-8-hydroxyquinolin-7-yl)-thiophen-2-ylmethyl]-2-methylpropanamide
• 化学式: C₁₈H₁₇ClN₂O₂S
• 分子量: 360.864
• InChiKey: MUXXALTZLCUMQQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  4.6
• 重原子数：
  24
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.22
• 拓扑面积：
  90.5
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• Small molecule activators of mitochondrial function
  申请人：THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA

  公开号：US10745390B2

  公开（公告）日：2020-08-18

  Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.

  通过使细胞或治疗对象接触通式化合物或组合物来改善线粒体功能、减少铁积累和/或降低氧化应激的方法 所述方法有益于治疗例如弗里德雷氏共济失调、正常衰老以及阿尔茨海默病和帕金森病等各种神经退行性疾病。此外，这类化合物还可作为探针，用于鉴定线粒体代谢、线粒体铁积累、细胞应激等线粒体疾病的缺陷，并帮助鉴定对克服这些缺陷具有活性的化合物。
• SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION
  申请人：Wilson Robert B.

  公开号：US20120041023A1

  公开（公告）日：2012-02-16

  Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula (I) are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.
• US9000009B2
  申请人：——

  公开号：US9000009B2

  公开（公告）日：2015-04-07
• US9695157B2
  申请人：——

  公开号：US9695157B2

  公开（公告）日：2017-07-04
• [EN] SMALL MOLECULE ACTIVATORS OF MITOCHONDRIAL FUNCTION<br/>[FR] ACTIVATEURS DE PETITES MOLÉCULES DE LA FONCTION MITOCHONDRIALE
  申请人：UNIV PENNSYLVANIA

  公开号：WO2010068767A1

  公开（公告）日：2010-06-17

  Methods for improving mitochondrial function, decreasing iron accumulation, and/or decreasing oxidative stress by exposing cells or treating a subject to compounds or compositions of the general formula (I) are described that are beneficial in treating, for example, diseases and conditions such as Friedreich's ataxia, normal aging, and various neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease. Furthermore, such compounds are useful as probes for identifying defects in mitochondrial metabolism, mitochondrial iron accumulation, cellular stress among other mitochondrial diseases and helping to identify compounds active in overcoming such defects.